Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a681026 |
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Major urinary metabolites are fenoprofen glucuronide and 4′-hydroxyfenoprofen glucuronide. |
Biological half-life | 3 hours |
Excretion | Renal (~90%) |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.047.356 |
Chemical and physical data | |
Formula | C15H14O3 |
Molar mass | 242.26986 g/mol |
3D model (Jmol) | |
|
|
|
|
Fenoprofen is a non-steroidal anti-inflammatory drug. Fenoprofen calcium is used for symptomatic relief for rheumatoid arthritis, osteoarthritis, and mild to moderate pain. Fenoprofen is marketed in the USA as Nalfon.
As of 2015 the cost for a typical month of medication in the United States is 50 to 100 USD.
Decreases inflammation, pain, and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.
History of significantly impaired renal function; patients with known hypersensitivity to any component of the product; patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs; treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
False elevation in free and total serum T 3 as measured by Amerlex-M kit.